📝 No template loaded.
VIEW QR REPORT LIST
| S.No | Date | Patient Name | File | QR | Action |
|---|
End of Topic
You have reached the end of this First-Trimester Ultrasound topic.
Content is intended for educational, training, and clinical reference only.
Declaration:
I, R. K. Mouj, declare that the material presented in this topic titled
“Nuchal Translucency (NT) Screening – First Trimester (11–13+6 Weeks)” has been prepared solely
for educational and academic purposes.
The screening parameters (CRL, NT measurement, nasal bone assessment, ductus venosus flow,
tricuspid regurgitation evaluation, FHR, and related risk markers) are described for structured
academic understanding.
NT screening is a risk assessment tool and not a definitive diagnostic test.
Accurate measurement requires adherence to standardized guidelines (e.g., proper fetal position,
mid-sagittal plane acquisition, magnification criteria).
Clinical correlation, certified risk calculation software, biochemical marker integration,
and professional medical judgment are essential before making any diagnostic or management decisions.
Author: ____________________
Name: R. K. Mouj [Radio-imaging Technologist]
Domain: Diagnostic Sonography & Obstetric Imaging
Special Focus: First-Trimester NT Screening & Early Fetal Risk Assessment
Platform: SonoAcademy
Supervisor / Guide: Department Radiologist
Department: Radiology
No comments:
Post a Comment